FDA Approves Teva Leukemia Treatment
The medication is approved for treatment of recently-diagnosed low-risk adults with acute promyelocytic leukemia (APL).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
![](https://www.jewishpress.com/wp-content/uploads/Jewish-Press-Small-Logo-Rectangle.jpg?v=1.0.5" style="display: none;){kind=logo}
